Eli Lilly Leads Both Innovation and Invention Rankings in Pharma R&D Performance
read at STAT ↗Positive
STAT+ reports that Eli Lilly captured the top positions in a prominent pharma R&D performance ranking, leading both the innovation and invention categories.
The rankings, compiled by UK-based IDEA Pharma of SAI MedPartners, assess laboratories on revenue from new products, recent approvals and major development events for innovation, and on the number of drugs in development, clinical trials and R&D spending for invention.
Lilly’s dual #1 placement marks the first instance a single company has topped both lists, underscoring its strong standing in the industry.
source
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: Eli Lilly tops prominent rankings on pharma R&D performance”
read at STAT ↗507 words · retrieved May 19
comments(0)
5-min edit window · permanent after that